Chesnara Plc: Fourth acquisition in two years
12 November 2026
Thermo Fisher Scientific Inc. (NYSE: TMO) stands out in the healthcare sector, particularly within the Diagnostics & Research industry, as a formidable player with a market..
argenx SE (ARGX) is capturing significant attention in the biotechnology sector with its compelling growth prospects and robust pipeline of therapies aimed at treating autoimmune diseases...
Doximity, Inc. (NYSE: DOCS), a leader in the digital healthcare space, has been garnering significant attention from investors, with a remarkable potential upside of 63.94%. As..
Takeda Pharmaceutical Company Limited (NYSE: TAK), a stalwart in the global healthcare sector, commands the attention of investors with its expansive portfolio and strategic collaborations. With..
Johnson & Johnson (NYSE: JNJ) remains a steadfast giant in the healthcare sector, known for its broad array of products spanning from pharmaceuticals to medical devices...
AstraZeneca PLC (NYSE: AZN), a global leader in the biopharmaceutical realm, continues to capture investor attention with its robust portfolio and promising financial outlook. With a..
Investors with a focus on the healthcare sector, particularly those interested in pioneering pharmaceutical innovations, should keep a close eye on Neurocrine Biosciences, Inc. (NBIX). This..
Cencora, Inc. (NYSE: COR), a leading player in the medical distribution industry, stands out in the healthcare sector with a market capitalization of $68.08 billion. Formerly..
Bio-Techne Corp (NASDAQ: TECH), a key player in the healthcare sector with a focus on biotechnology, presents an intriguing opportunity for investors with its substantial potential..
As the demand for healthcare solutions continues to escalate globally, STERIS plc (NYSE: STE) stands out as a formidable player in the medical devices industry. With..
ResMed Inc. (NYSE: RMD), a prominent player in the healthcare sector, is attracting investor attention with its potential 28.6% upside based on current analyst ratings. Operating..
Bristol-Myers Squibb Company (NYSE: BMY), a giant in the healthcare sector, has long been a cornerstone in the biopharmaceutical industry, delivering innovative treatments across oncology, hematology,..
Medpace Holdings, Inc. (NASDAQ: MEDP), a prominent player in the healthcare sector, specializes in diagnostics and research, offering an extensive suite of clinical development services. With..
Universal Health Services, Inc. (NYSE: UHS) is drawing investor attention with its impressive potential upside of 29.28%, based on the current stock price of $192.42 and..
Moderna, Inc. (NASDAQ: MRNA) stands as a formidable player in the biotechnology sector, primarily recognized for its pioneering work in mRNA medicines. As the company navigates..
In the dynamic world of biopharmaceuticals, United Therapeutics Corporation (NASDAQ: UTHR) continues to make waves with its innovative approach to treating chronic and life-threatening diseases. As..
For investors seeking opportunities in the healthcare sector, AbbVie Inc. (NYSE: ABBV) stands out as a formidable player with a robust portfolio of pharmaceutical products and..
HealthEquity, Inc. (NASDAQ: HQY) stands at a compelling juncture for investors, offering a significant potential upside of 47.07%, underpinned by a strong consensus among analysts. As..
Haleon plc (HLN), a prominent player in the healthcare sector, has recently captured investor attention with its potential upside of 18.92%. While the company’s roots trace..
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a prominent player in the biotechnology sector, is capturing investor attention with its compelling growth trajectory and promising market positioning. With..
